We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Clinical Trial Directive Places Greater Burden on Smaller Drugmakers
EU Clinical Trial Directive Places Greater Burden on Smaller Drugmakers
November 22, 2005
While the main thrust of the European Union's Clinical Trial Directive is to better protect study participants, it is also intended to make the EU more attractive for clinical research by shortening the approval process for trials and streamlining bureaucracy.